HL7 FHIR Implementation Guide: Profiles for Transfusion and Vaccination Adverse Event Detection and Reporting
1.0.1 - STU 1 Technical Correction United States of America flag

HL7 FHIR Implementation Guide: Profiles for Transfusion and Vaccination Adverse Event Detection and Reporting, published by Biomedical Research & Regulation WG. This is not an authorized publication; it is the continuous build for version 1.0.1). This version is based on the current content of https://github.com/HL7/fhir-icsr-ae-reporting/ and changes regularly. See the Directory of published versions

: Transfusion-related Adverse Events - JSON Representation

Draft as of 2023-08-30

Raw json | Download


{
  "resourceType" : "ValueSet",
  "id" : "MedDRATransfusionAdverseEventVS",
  "text" : {
    "status" : "additional",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\">Placeholder</div>"
  },
  "url" : "http://hl7.org/fhir/us/icsr-ae-reporting/ValueSet/MedDRATransfusionAdverseEventVS",
  "version" : "1.0.1",
  "name" : "MedDRATransfusionAdverseEventVS",
  "title" : "Transfusion-related Adverse Events",
  "status" : "draft",
  "experimental" : false,
  "date" : "2023-08-30T17:02:44+00:00",
  "publisher" : "Biomedical Research & Regulation WG",
  "contact" : [
    {
      "name" : "Biomedical Research & Regulation WG",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://hl7.org/Special/committees/rcrim"
        }
      ]
    },
    {
      "name" : "Jean Duteau",
      "telecom" : [
        {
          "system" : "email",
          "value" : "mailto:jean.duteau@ibm.com"
        }
      ]
    }
  ],
  "description" : "MedDRA codes that represent the specific transfusion adverse events that are considered by this Implementation Guide",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US",
          "display" : "United States of America"
        }
      ]
    }
  ],
  "copyright" : "MedDRA® is a registered trademark of the International Federation of Pharmaceutical Manufacturers and Associations.  All rights reserved."
}